307 related articles for article (PubMed ID: 19681636)
1. Fullerenol-cytotoxic conjugates for cancer chemotherapy.
Chaudhuri P; Paraskar A; Soni S; Mashelkar RA; Sengupta S
ACS Nano; 2009 Sep; 3(9):2505-14. PubMed ID: 19681636
[TBL] [Abstract][Full Text] [Related]
2. Shape effect of carbon nanovectors on angiogenesis.
Chaudhuri P; Harfouche R; Soni S; Hentschel DM; Sengupta S
ACS Nano; 2010 Jan; 4(1):574-82. PubMed ID: 20043662
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
[TBL] [Abstract][Full Text] [Related]
4. Single-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanoma.
Chaudhuri P; Soni S; Sengupta S
Nanotechnology; 2010 Jan; 21(2):025102. PubMed ID: 19955607
[TBL] [Abstract][Full Text] [Related]
5. Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate.
Li X; Li R; Qian X; Ding Y; Tu Y; Guo R; Hu Y; Jiang X; Guo W; Liu B
Eur J Pharm Biopharm; 2008 Nov; 70(3):726-34. PubMed ID: 18634874
[TBL] [Abstract][Full Text] [Related]
6. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
[TBL] [Abstract][Full Text] [Related]
7. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
[TBL] [Abstract][Full Text] [Related]
8. Fullerene-conjugated doxorubicin in cells.
Liu JH; Cao L; Luo PG; Yang ST; Lu F; Wang H; Meziani MJ; Haque SA; Liu Y; Lacher S; Sun YP
ACS Appl Mater Interfaces; 2010 May; 2(5):1384-9. PubMed ID: 20420365
[TBL] [Abstract][Full Text] [Related]
9. Cationic supramolecular nanoparticles for co-delivery of gene and anticancer drug.
Hu QD; Fan H; Ping Y; Liang WQ; Tang GP; Li J
Chem Commun (Camb); 2011 May; 47(19):5572-4. PubMed ID: 21468443
[TBL] [Abstract][Full Text] [Related]
10. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
11. [New conjugates of antitumor antibiotic doxorubicin with water-soluble galactomannan: synthesis and biological activity].
Teviashova AN; Olsuf'eva EN; Preobrazhenskaia MN; Klesov AA; Zomer E; Platt D
Bioorg Khim; 2007; 33(1):148-55. PubMed ID: 17375669
[TBL] [Abstract][Full Text] [Related]
12. Supramolecular chemistry on water-soluble carbon nanotubes for drug loading and delivery.
Liu Z; Sun X; Nakayama-Ratchford N; Dai H
ACS Nano; 2007 Aug; 1(1):50-6. PubMed ID: 19203129
[TBL] [Abstract][Full Text] [Related]
13. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
14. Preparation and anti-tumor efficiency evaluation of doxorubicin-loaded bacterial magnetosomes: magnetic nanoparticles as drug carriers isolated from Magnetospirillum gryphiswaldense.
Sun JB; Duan JH; Dai SL; Ren J; Guo L; Jiang W; Li Y
Biotechnol Bioeng; 2008 Dec; 101(6):1313-20. PubMed ID: 18980188
[TBL] [Abstract][Full Text] [Related]
15. New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.
Ché C; Yang G; Thiot C; Lacoste MC; Currie JC; Demeule M; Régina A; Béliveau R; Castaigne JP
J Med Chem; 2010 Apr; 53(7):2814-24. PubMed ID: 20210346
[TBL] [Abstract][Full Text] [Related]
16. Star-shaped nano-conjugates of cisplatin with high drug payload.
Kowalczuk A; Stoyanova E; Mitova V; Shestakova P; Momekov G; Momekova D; Koseva N
Int J Pharm; 2011 Feb; 404(1-2):220-30. PubMed ID: 21078377
[TBL] [Abstract][Full Text] [Related]
17. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of N-succinyl-N'-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity.
Xiangyang X; Ling L; Jianping Z; Shiyue L; Jie Y; Xiaojin Y; Jinsheng R
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):222-8. PubMed ID: 17254755
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable ZnO@polymer core-shell nanocarriers: pH-triggered release of doxorubicin in vitro.
Zhang ZY; Xu YD; Ma YY; Qiu LL; Wang Y; Kong JL; Xiong HM
Angew Chem Int Ed Engl; 2013 Apr; 52(15):4127-31. PubMed ID: 23463695
[No Abstract] [Full Text] [Related]
20. Improved therapeutic efficacy of doxorubicin through conjugation with a novel peptide drug delivery technology (Vectocell).
Meyer-Losic F; Quinonero J; Dubois V; Alluis B; Dechambre M; Michel M; Cailler F; Fernandez AM; Trouet A; Kearsey J
J Med Chem; 2006 Nov; 49(23):6908-16. PubMed ID: 17154520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]